510(k) Report

510(k) · Cleared

Cleared

Mastergraft Resorbable Ceramic Granules

K082917510(k) TraditionalCleared Jan 9, 2009101-day reviewClass II21 CFR 872.3930

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic Sofamor Danek · LYC Bone Grafting Material, Synthetic

Cleared on Jan 9, 2009 as substantially equivalent to K020986 (Medtronic Sofamor Danek, Inc., 2002) and 1 other predicate after a 101-day review. Its family tree reaches back 5 generations to 1999. 3 later devices descend from it.

Decided
Jan 9, 2009
Review
101 days
Class
Class II
Product code
LYC
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K990131 (1999). 6 ancestors in all. 3 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor2010: 2 descendants cleared2009: 1 descendant clearedK990131 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute · Interpore Cross Intl. · 1999K020986 · Mastergraft Resorbable Ceramic · Medtronic Sofamor Danek, Inc. · 2002K032268 · MBCP · Biomatlante · 2003K043005 · Modification to MBCP · Biomatlante · 2005K051885 · MBCP · Biomatlante · 20051995200020052010201520202025
  1. Root · 5 generations backK990131 Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl. · 1999
  2. 4 generations backK020986 Mastergraft Resorbable CeramicMedtronic Sofamor Danek, Inc. · 2002
  3. 3 generations backK032268 MBCPBiomatlante · 2003
  4. 2 generations backK043005 Modification to MBCPBiomatlante · 2005
  5. 1 generation backK051885 MBCPBiomatlante · 2005
  6. This deviceK082917 Mastergraft Resorbable Ceramic GranulesMedtronic Sofamor Danek · 2009
  7. Descendant · cites it directly · 0 of its ownK100986 Callos Bone Void Filler, Skaffold Next Generation Bone Void Filler…Skeletal Kinetics, LLC · 2010 · Recalled
  8. Descendant · cites it directly · 0 of its ownK093871 Periophil B-TCPCytophil, Inc. · 2010
  9. Descendant · cites it directly · 0 of its ownK092087 Medtronic Dental TCPMedtronic Sofamor Danek USA, Inc. · 2009

Most influential descendants

Showing 3 of 3 · See all
  • K100986Callos Bone Void Filler, Skaffold Next Generation Bone Void Filler, Osteo VationSkeletal Kinetics, LLC · 2010 · cites it directly0descendants
  • K093871Periophil B-TCPCytophil, Inc. · 2010 · cites it directly0descendants
  • K092087Medtronic Dental TCPMedtronic Sofamor Danek USA, Inc. · 2009 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K990131Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl.1999—
−4K020986Mastergraft Resorbable CeramicMedtronic Sofamor Danek, Inc.2002—
−3K032268MBCPBiomatlante2003—
−2K043005Modification to MBCPBiomatlante2005—
−1K051885MBCPBiomatlante2005—
0 (this device)K082917Mastergraft Resorbable Ceramic GranulesMedtronic Sofamor Danek2009—
+1K100986Callos Bone Void Filler, Skaffold Next Generation Bone Void Filler, Osteo VationSkeletal Kinetics, LLC201011
+1K093871Periophil B-TCPCytophil, Inc.2010—
+1K092087Medtronic Dental TCPMedtronic Sofamor Danek USA, Inc.2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201020
FIG. 1 — Lineage of K082917, 1999–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LYC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LYC device

  1. #1 K253317 Cytrans™ Elashieldscore 14.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K020986Mastergraft Resorbable Ceramic
Summary page 1
…so that it may be used in the oral and maxillofacial region. Like the previously cleared predicates, MASTERGRAFT® Resorbable Ceramic Granules (K020986, SE 07/22/2002) and MBCP TM (K051885, SE 09116/2005), the subject system is intended to be used alone o…
Medtronic Sofamor Danek, Inc.2002—
*K051885MBCP
Summary page 1
…nd maxillofacial region. Like the previously cleared predicates, MASTERGRAFT® Resorbable Ceramic Granules (K020986, SE 07/22/2002) and MBCP TM (K051885, SE 09116/2005), the subject system is intended to be used alone or combined with autograft as a bone void filler…
Biomatlante2005—

Also cleared against K020986: 8 other devices →

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K100986Callos Bone Void Filler, Skaffold Next Generation Bone Void Filler, Osteo VationSkeletal Kinetics, LLC20100
K093871Periophil B-TCPCytophil, Inc.20100
K092087Medtronic Dental TCPMedtronic Sofamor Danek USA, Inc.20090

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 4 companies; a new generation was cleared every 1.4 years on median.
  • None of the 6 ancestors has a recall.
  • Of its descendants, K100986 (Skeletal Kinetics, LLC, 2010) has gone furthest, with 0 descendants of its own.
  • 8 other devices also cite its predicate K020986.

How does its category compare?

All LYC devices

LYC Bone Grafting Material, Synthetic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · LYC

3in 2025

2007: 132008: 82009: 142010: 132011: 92012: 52013: 22014: 12016: 22020: 32022: 22025: 32026 (partial year): 3
2007high 14 (2009) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LYC

267in 2025

2007: 80 days median2008: 73 days median2009: 100 days median2010: 164 days median2011: 224 days median2012: 120 days median2020: 156 days median2025: 267 days median2026 (partial year): 266 days median
2007high 267 (2025) · low 73 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LYC

1in 2018

2009: 12010: 22012: 22016: 22018: 1
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LYC

2in 2025

2007: 232008: 252009: 252010: 282011: 212012: 102013: 122014: 92015: 142016: 1402017: 192018: 142019: 152020: 52021: 122022: 62023: 92024: 62025: 2
2007high 140 (2016) · low 2 (2025)2025

MAUDE reports naming product code LYC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071380023
2008873025
200914100125
201013164228
20119224021
20125120210
20132—012
20141—09
20150—014
20162—2140
20170—019
20180—114
20190—015
2020315605
20210—012
20222—06
20230—09
20240—06
2025326702
202632660—

What is it indicated for?

MASTERGRAFT® Resorbable Ceramic Granules may be used alone or in combination with autograft to provide a bone void filler that is resorbed/remodeled and is replaced by host bone during the healing process. MASTERGRAFT® Resorbable Ceramic Granules is packed into bony voids or gaps to fill and/or augment dental oral/maxillofacial bony tissue. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the…

Read the full statement (149 words)

MASTERGRAFT® Resorbable Ceramic Granules may be used alone or in combination with autograft to provide a bone void filler that is resorbed/remodeled and is replaced by host bone during the healing process. MASTERGRAFT® Resorbable Ceramic Granules is packed into bony voids or gaps to fill and/or augment dental oral/maxillofacial bony tissue. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone.

Procedures specific to MASTERGRAFT® Granules include:

• Filling of dental extraction sockets

• Filling of cystic defects

• Oral/maxillofacial augmentation or reconstruction.

Procedures specific to MASTERGRAFT® Mini Granules include:

• Filling of periodontal defects

• Sinus lifts

• Alveolar ridge augmentation

• Filling of dental extraction sockets

• Filling of cystic defects

• Oral/maxillofacial augmentation or reconstruction.

MASTERGRAFT® Resorbable Ceramic Granules may be used with or without internal fixation, and may be mixed with autograft as a bone graft extender.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082917: Mastergraft Resorbable Ceramic Granules.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K082917

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026